{"version":"1.0","type":"link","title":"Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerability.","author_name":"Ruiter G 외","author_url":"https://prs-insight.online/author/Ruiter%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95442","thumbnail_width":1200,"thumbnail_height":630}